Evaluating the Feasibility and Acceptability of Implementing a PrEP Program in PR-CoNCRA (San Juan, Puerto Rico)- Part B
Phase of Trial: Phase IV
Latest Information Update: 07 Nov 2019
Price : $35 *
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms PR-CoNCRA
- 04 Apr 2018 Planned End Date changed from 1 Jun 2018 to 1 Nov 2019.
- 04 Apr 2018 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2019.
- 20 Apr 2017 New trial record